Abstract:
Pharmaceutical manufacturing industry is expected to generate effluents having a wide
variety of antimicrobial substances. The biological wastewater treatment processes
should thus be capable of handling effluents, containing these inhibitory materials,
without being adversely affected.
In this investigation, the study of the wastewater treatment system of a Pharmaceutical
Manufacturing facility is carried out with special reference to antimicrobial discharges.
The manufacturing process studied dealt with formulation, filling and packaging of
preparation for prescription products. Thus this facility falls into the 'dry formulation'
category. A good clean supply of water is essential in this industry. The water used in the
manufacturing areas is mainly for cleaning/washing of processing equipment and
accessories. Water is also used for cooling the housing of the moving parts in machines.
All liquid effluents generated pass through a wastewater treatment plant prior to
discharge into an inland surface water body.
The wastewater treatment plant in this facility consists of an activated sludge treatment
process. For a primary understanding of this wastewater treatment plant a study of the
general characteristics were done. The effect on the overall efficiency of the wastewater
treatment plant was observed while studying the washing/cleaning activities carried out
in the production zones on each sample collecting day. The findings of this study showed
an overall efficiency less than the design efficiency of the wastewater treatment plant. It
is seen that plant inputs and generated waste loads are low even when compared with
typical waste characteristics of such facilities. A large fraction of the BOD/COD ratios
determined showed low values. About 92% of the BOD/COD ratios determined in the
equalization tank were less than 0.5. The analysis of BOD, with different dilutions was
done in order to determine whether there is an effect by any antimicrobial substance on
the biological activity.
IV
The BOD test carried out for a series of wastewater sample dilutions showed decreasing
BOD values as the dilution percentage increasing on certain days. In some days results
showed 31% to 34% reduction in BOD value indicating the presence of an antimicrobial
substance in the wastewater sample on that day.
Further, in order to study the antimicrobial activity of the wastewater discharged from
this facility, E. coli was tested in liquid culture medium. The growth of E. coli was
monitored as absorbance at 600nm in the presence and absence of waste samples.
The results indicated the growth of E. coli in wastewater was not as high as the growth
shown in the peptone water medium. It was also indicated that the growth of this
organism in the wastewater sample was not inhibitory as in the solution containing
amoxycillin (1011g/ml).
A study of the effect on the same organism was also carried out using the antibiotic
diffusion technique. The inhibition zones created from a concentration series of an
antimicrobial substance were studied with the inhibition zone produced by wastewater.
The study carried out using the cylinder plate test showed an inhibition zone for
wastewater. For a wastewater sample taken from the wastewater treatment plant after
cleaning Rifampicin processed machines, a clear zone was observed giving an effect
equivalent to a concentration of2.9 ug of amoxycillin per milliliter.
From the observed results, heavy impact on the wastewater treatment plant operation
from discharges was not indicated. However the precautions are needed to be taken when
contemplating expansion etc. as the present observations and conclusions apply only to
current loading conditions. Close monitor of waste effluent would be necessary in future
if expansion is sought by the company.